← Back to Search

Respiratory Training for Muscle Tension Voice Disorder

N/A
Recruiting
Led By Soren Y Lowell, PhD
Research Sponsored by Syracuse University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adequate visual acuity (with or without corrective lenses) to read basic graphs and print, as determined with visual screening
Self-report of normal pulmonary function
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed during initial baseline testing and approximately 7 weeks later directly after training completion.
Awards & highlights

Study Summary

This trial is studying the effects of two different types of respiratory training on people with primary muscle tension dysphonia, a voice disorder that causes the voice to sound hoarse and strained.

Who is the study for?
Adults over 18 with Muscle Tension Dysphonia (MTD) diagnosed by a specialist, experiencing voice strain and breathing issues for more than 2 months. Participants must be non-smokers for at least 5 years, in good health aside from MTD, have normal vision (with glasses if needed), not currently undergoing other voice treatments, and speak English as their primary language.Check my eligibility
What is being tested?
The trial is testing two types of respiratory training to improve voice in people with MTD: one using a device and the other without. The study will compare the effects on breathing patterns and voice quality immediately after training, then again at 3 and 6 months post-training.See study design
What are the potential side effects?
Since this trial involves non-invasive breathing exercises rather than medication or surgery, significant side effects are not expected. However, participants may experience temporary discomfort or fatigue from the exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can read graphs and print clearly, with or without glasses.
Select...
I believe my lung function is normal.
Select...
I have not smoked for at least 5 years.
Select...
I do not have any other voice disorders like spasmodic dysphonia or vocal fold paralysis.
Select...
My vocal cords close normally, except for the back part which may not fully close.
Select...
I do not have trouble swallowing.
Select...
I am not currently undergoing any voice therapy that can't be stopped.
Select...
I am 18 years old or older.
Select...
I have never had surgery on my vocal cords.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed during initial baseline testing and approximately 7 weeks later directly after training completion.
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed during initial baseline testing and approximately 7 weeks later directly after training completion. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cepstral Peak Prominence
Change in Cepstral/Spectral Index of Dysphonia
Change in Lung Volume Excursion
+2 more
Secondary outcome measures
Change in Auditory-Perceptual Overall Severity of Voice Disorder
Change in Voice Handicap Index-10

Trial Design

2Treatment groups
Active Control
Group I: Breathing training with a deviceActive Control1 Intervention
Respiratory intervention delivered once a week for 6 weeks, after two initial baseline testing sessions. Participants will perform exhalation exercises through a breathing device. Homework activities will be assigned. Post-training testing sessions will also be conducted.
Group II: Breathing training without a deviceActive Control1 Intervention
Respiratory intervention delivered once a week for 6 weeks, after two initial baseline testing sessions. Participants will receive training on the use of breathing techniques without a device, but with visual feedback throughout training. Homework activities will be assigned. Post-training testing sessions will also be conducted.

Find a Location

Who is running the clinical trial?

Syracuse UniversityLead Sponsor
48 Previous Clinical Trials
117,538 Total Patients Enrolled
Soren Y Lowell, PhDPrincipal InvestigatorSyracuse University
1 Previous Clinical Trials
17 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients being sought for this research project at the moment?

"That is accurate. According to the information available on clinicaltrials.gov, this ongoing trial posted 5/12/2021 seeks 36 participants from a single site."

Answered by AI

How large is the cohort for this clinical trial?

"That is accurate. As of 8/18/2022, the study detailed on clinicaltrials.gov was actively recruiting 36 patients from a single location."

Answered by AI
~2 spots leftby Jun 2024